Healthcare

Nucleus

Nucleus RadioPharma was founded in 2022 through a partnership with Mayo Clinic and Eclipse. Our purpose is to ensure that the promise of new drugs for radioligand therapy reach the cancer patient.

To do this, Nucleus is building world’s first fully integrated manufacturing, supply chain, and clinical operations company focused specifically on radiopharmaceuticals and theranostics. It is the first fully integrated solution enabling our partners to design, test, and scale production of new radiopharmaceuticals, drive successful trials, secure distribution and redundancy, and reduce delays from order to final delivery that will meet the needs of the medical community, all within the same ecosystem.